Related Experiment Video

Updated: Aug 11, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
10:22

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Published on: November 12, 2015

Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells

X Zheng1, X-M Rao, C L Snodgrass

  • 1James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Cancer Gene Therapy
|December 13, 2005
PubMed

Insights

E1B55K-deleted adenoviruses show selective replication in cancer cells. The E1B55K protein enhances E1A expression, improving viral replication in resistant cancer cells and potentially increasing antitumor efficacy.

Area of Science:

  • Oncolytic virotherapy
  • Adenovirus research
  • Cancer cell biology

Background:

  • E1B55K-deleted dl1520 adenoviruses are investigated for antitumor properties due to selective cancer cell replication.
  • The precise mechanisms driving this selective replication, particularly the role of p53, remain incompletely understood.
  • Variability in dl1520 replication exists across cancer cell lines, with some exhibiting resistance irrespective of p53 status.

Purpose of the Study:

  • To elucidate the replication capabilities of E1B55K-deleted adenoviruses in p53-null cancer cell lines (Hep3B and Saos2) with varying E1A expression levels.
  • To investigate the influence of E1A expression levels on adenovirus replication in different cancer cell contexts.
  • To determine the role of the viral E1B55K protein in modulating E1A expression and its impact on adenovirus replication.

Main Methods:

  • Utilized p53-null Hep3B and Saos2 cancer cell lines as model systems.
  • Compared the replication efficiency of E1B55K-deleted adenoviruses with different E1A expression levels.
  • Analyzed E1a promoter activity and the impact of E1B55K protein on E1A expression.

Main Results:

  • Lower E1A expression in Saos2 cells correlated with poor adenovirus replication, linked to reduced E1a promoter activation compared to Hep3B cells.
  • The viral E1B55K protein was shown to enhance E1A expression in Saos2 cells, facilitating efficient virus replication.
  • Transcriptional activity of the E1a promoter's upstream regions was observed in Hep3B but not in Saos2 cells, suggesting E1B55K may activate cellular factors to boost E1A expression.

Conclusions:

  • This study is the first to demonstrate that the E1B55K protein influences E1A production levels, directly impacting cancer-selective replication.
  • Increased E1A expression, potentially mediated by E1B55K, could enhance the killing of cancer cells that are otherwise resistant to E1b-deleted adenovirus replication.
  • Findings suggest a strategy to improve the efficacy of oncolytic adenoviruses by manipulating E1A expression for broader cancer cell targeting.

More Related Videos

An Efficient Method for Adenovirus Production10:06

An Efficient Method for Adenovirus Production

Published on: June 10, 2021

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...